Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery

por Shinoda, Shuhei, Nakamura, Naohiko, Roach, Brett, Bernlohr, David A., Ikramuddin, Sayeed, Yamamoto, Masato
Publicado 2022

Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model

por Shinoda, Shuhei, Sharma, Nikita S., Nakamura, Naohiko, Inoko, Kazuho, Sato‐Dahlman, Mizuho, Murugan, Paari, Davydova, Julia, Yamamoto, Masato
Publicado 2023

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

por Harima, Hirofumi, Kaino, Seiji, Takami, Taro, Shinoda, Shuhei, Matsumoto, Toshihiko, Fujisawa, Koichi, Yamamoto, Naoki, Yamasaki, Takahiro, Sakaida, Isao
Publicado 2016

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

por Amano, Shogo, Kaino, Seiji, Shinoda, Shuhei, Harima, Hirofumi, Matsumoto, Toshihiko, Fujisawa, Koichi, Takami, Taro, Yamamoto, Naoki, Yamasaki, Takahiro, Sakaida, Isao
Publicado 2023

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo

por Shinoda, Shuhei, Kaino, Seiji, Amano, Shogo, Harima, Hirofumi, Matsumoto, Toshihiko, Fujisawa, Koichi, Takami, Taro, Yamamoto, Naoki, Yamasaki, Takahiro, Sakaida, Isao
Publicado 2018

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

por Amano, Shogo, Kaino, Seiji, Shinoda, Shuhei, Harima, Hirofumi, Matsumoto, Toshihiko, Fujisawa, Koichi, Takami, Taro, Yamamoto, Naoki, Yamasaki, Takahiro, Sakaida, Isao
Publicado 2020

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia

por Amano, Shogo, Suenaga, Shigeyuki, Hamamoto, Kaori, Yada, Shoko, Tsuyama, Takanori, Shinoda, Shuhei, Tanaka, Yuya, Takemoto, Yoshihiro, Harada, Eijiro, Tanabe, Katsuya, Asahara, Shunichiro, Hoshii, Kazunobu, Takami, Taro
Publicado 2023